Vranken JH - Search Results

1

Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.

van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. van Beers EJ, et al. Among authors: vranken jh. Am J Hematol. 2007 Nov;82(11):955-60. doi: 10.1002/ajh.20944. Am J Hematol. 2007. PMID: 17617790 Free article. Clinical Trial.

2

Mechanisms and treatment of neuropathic pain.

Vranken JH. Vranken JH. Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):71-8. doi: 10.2174/187152409787601932. Cent Nerv Syst Agents Med Chem. 2009. PMID: 20021340

3

Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine.

Vranken JH, Troost D, de Haan P, Pennings FA, van der Vegt MH, Dijkgraaf MG, Hollmann MW. Vranken JH, et al. Anesthesiology. 2006 Oct;105(4):813-8. doi: 10.1097/00000542-200610000-00028. Anesthesiology. 2006. PMID: 17006081 Free article.

4

Continuous sacral nerve root block in the management of neuropathic cancer pain.

Vranken JH, Van Der Vegt MH, Ubags LH, Pijl AJ, Dzoljic M. Vranken JH, et al. Anesth Analg. 2002 Dec;95(6):1724-5, table of contents. doi: 10.1097/00000539-200212000-00047. Anesth Analg. 2002. PMID: 12456447

5

[Coeliac plexus block in patients with pancreatic tumour pain].

Vranken JH, van der Vegt MH. Vranken JH, et al. Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):723-8. Ned Tijdschr Geneeskd. 2006. PMID: 16623345 Review. Dutch.

6

Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial.

Vranken JH, Hollmann MW, van der Vegt MH, Kruis MR, Heesen M, Vos K, Pijl AJ, Dijkgraaf MGW. Vranken JH, et al. Pain. 2011 Feb;152(2):267-273. doi: 10.1016/j.pain.2010.09.005. Pain. 2011. PMID: 21078545 Clinical Trial.

7

Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen.

Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Vranken JH, et al. Pain. 2008 May;136(1-2):150-7. doi: 10.1016/j.pain.2007.06.033. Epub 2007 Aug 20. Pain. 2008. PMID: 17703885 Clinical Trial.

8

Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial.

Vranken JH, Dijkgraaf MG, Kruis MR, van Dasselaar NT, van der Vegt MH. Vranken JH, et al. Pain. 2005 Nov;118(1-2):224-31. doi: 10.1016/j.pain.2005.08.020. Epub 2005 Oct 3. Pain. 2005. PMID: 16202531 Clinical Trial.

9

Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain.

Vranken JH, Troost D, Wegener JT, Kruis MR, van der Vegt MH. Vranken JH, et al. Pain. 2005 Sep;117(1-2):231-5. doi: 10.1016/j.pain.2005.06.014. Pain. 2005. PMID: 16098665

10

Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain.

Vranken JH, van der Vegt MH, van Kan HJ, Kruis MR. Vranken JH, et al. Acta Anaesthesiol Scand. 2005 May;49(5):665-70. doi: 10.1111/j.1399-6576.2005.00667.x. Acta Anaesthesiol Scand. 2005. PMID: 15836681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results